General Updates

September 17, 2026 BSE Limited National Stock Exchange of India Limited Corporate Relation Department Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block - G Dalal Street Bandra-Kurla Complex Mumbai – 400001 Bandra (East), Mumbai - 400051 Scrip Code: 524404 Symbol: MARKSANS Sub.: Intimation regarding opening of Special Window for Re-lodgment of Transfer Requests of Physical Shares. Dear Sir/Madam, In order to facilitate ease of investing for investors and to secure their rights in the securities purchased by them, Securities and Exchange Board of India, vide its Circular No. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated January 30, 2026, has extended the special window to facilitate re-lodgment of transfer deeds that were lodged with respect to shares purchased/sold prior to April 1, 2019 but were rejected, returned or not attended to due to deficiencies in transfer documents or other reasons. In connection with the above matter, enclosed herewith kindly find a public notice for information of shareholders of the Company. Thanking you. Yours faithfully For Marksans Pharma Limited Harshavardhan Panigrahi Company Secretary Marksans Pharma Ltd. 11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 Tel.: +91 22 4001 2000 E-mail: companysecretary@marksanspharma.com www.marksanspharma.com NOTICE TO SHAREHOLDERS Special Window for Re-lodgement of Transfer Requests of Physical Shares SEBI, vide its Circular No. HO/38/13/11(2)2026-MIRSD-POD/ I/3750/2026 dated January 30, 2026, has extended a special window to facilitate re-lodgement of transfer deeds that were lodged with respect to shares purchased/sold prior to April 1, 2019 but were rejected, returned or not attended to due to deficiencies in transfer documents or other reasons. This special window is open for a period of one year from February 5, 2026 to February 4, 2027. Shareholders, who are still holding shares in physical mode which were purchased before April 1, 2019 but could not be transferred in their names as above, may take the advantage of this window and re-lodge the transfer deeds along with the share certificates, complete in all respect for registering the transfer. Please note that, if the transfer documents are found in order, transfer will be registered and shares will be credited to the transferee only in demat mode. No physical share certificates will be issued. Further note that the shares so credited will be under lock-in for a period of one year from the date of registration of transfer. Such shares shall not be transferred/lien-marked/pledged during the said lock-in period. The transferee shall be mandatorily required to submit the following documents: a. Original share certificate; b. Transfer deed executed prior to April 1, 2019; c. Proof of purchase by transferee; d. KYC documents of the transferee (as per ISR forms); e. Latest Client Master List of the demat account of the transferee, duly attested by the depository participant; and f. Undertaking cum Indemnity as per prescribed format (can be downloaded from www.marksanspharma.com g. Such other documents as may be required on case to case basis. Please note that cases involving disputes between transferor and transferee (to be settled through court process) and shares transferred to IEPF shall not be considered under this window for processing. Shareholders who wish to re-lodge their documents for transfer of shares are requested to contact the Company's Registrar and Share Transfer Agent (RTA), Bigshare Services Private Limited, at: Office No. S6-2, 6th Floor, Pinnacle Business Park, Andheri (East), Mumbai – 400093, Tel: 022 62638200. In case of any query, shareholders can send e-mail to RTA at info@bigshareonline.com or to the Company at companysecretary@marksanspharma.com. Shareholders may also contact the Company’s Mr. Atul Shukla on 022 4001 2000. ***** Marksans Pharma Ltd. 11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 Tel.: +91 22 4001 2000 E-mail: companysecretary@marksanspharma.com www.marksanspharma.com